Edition:
United States

Oculus Innovative Sciences Inc (OCLS.OQ)

OCLS.OQ on NASDAQ Stock Exchange Capital Market

4.29USD
26 Aug 2016
Change (% chg)

$-0.20 (-4.45%)
Prev Close
$4.49
Open
$4.45
Day's High
$4.45
Day's Low
$4.14
Volume
14,050
Avg. Vol
12,331
52-wk High
$7.20
52-wk Low
$3.61

OCLS.OQ

Chart for OCLS.OQ

About

Oculus Innovative Sciences, Inc. is a specialty pharmaceutical company, which focuses on identifying, developing and commercializing therapies to manage the lives of patients with dermatologic diseases or conditions. The Company's products treat certain topical skin diseases, including acne, atopic dermatitis, scarring,... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $18.02
Shares Outstanding(Mil.): 4.20
Dividend: --
Yield (%): --

Financials

  OCLS.OQ Industry Sector
P/E (TTM): -- 36.93 36.63
EPS (TTM): -2.93 -- --
ROI: -107.87 14.69 14.12
ROE: -110.02 15.48 15.04

BRIEF-Oculus Innovative Sciences receives U.S. FDA approval for new post dermal procedures product

* Got new 510(k) clearance from u.s. Fda for company's new post-dermal-procedures product

Aug 24 2016

BRIEF-Oculus Innovative sciences Q1 revenue $3.8 million versus $3.7 million

* Oculus innovative sciences reports financial results for first quarter of fiscal year 2017

Jul 28 2016

BRIEF-Oculus Innovative Sciences received European approval to market Sinudox

* Receives European approval to market Sinudox indicated for use in nasal irrigation

Apr 13 2016

Facebook's Oculus starts shipping Rift virtual reality headset

Virtual reality company Oculus started shipping its highly awaited Rift headsets from Monday, about two years after the company was acquired by social media giant Facebook Inc . | Video

Mar 28 2016

Facebook's Oculus starts shipping Rift virtual reality headset

March 28 Virtual reality company Oculus started shipping its highly awaited Rift headsets from Monday, about two years after the company was acquired by social media giant Facebook Inc.

Mar 28 2016

BRIEF-Oculus Innovative Sciences announces pricing of $3.4 MLN underwritten public offering

* Oculus innovative sciences announces pricing of $3.4 million underwritten public offering

Mar 18 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Wright Reports
$75.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.